Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2026 08:00 ET | Source: CYTOMED THERAPEUTICS LIMITED

CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital

SINGAPORE, Jan. 13, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on...
January 08, 2026 08:00 ET | Source: Alps Group Inc

Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer

KUALA LUMPUR, Malaysia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (NASDAQ: ALPS) (the “Company” or “Alps Group”), a fully integrated biotechnology research and healthcare platform...
January 06, 2026 09:07 ET | Source: Research and Markets

Bio/Pharmaceutical Outsourcing Market Research Report, November 2025: Transforming US Drug Access and Production - MFN Pricing Deals and Historic Manufacturing Investments

Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, November 2025" report has been added to ResearchAndMarkets.com's offering.The Bio/Pharmaceutical Outsourcing...
January 06, 2026 08:19 ET | Source: Coeptis Therapeutics

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, , announced...
January 05, 2026 10:24 ET | Source: Research and Markets

Gene Therapy R&D Market Forecast Report 2025-2035: Focus on Cancer, Rare Diseases, Cardiovascular, Ophthalmic, Haematology, Neurological, Diabetes Mellitus

Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy R&D Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. Overall world revenue for the Gene Therapy...
January 05, 2026 07:00 ET | Source: Marker Therapeutics

Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer

Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.6% disease control rate in patients with pancreatic cancer in Arm A of the clinical study Study...
December 29, 2025 09:15 ET | Source: Longeveron

Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026

Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Week 2026.
December 19, 2025 16:04 ET | Source: NurExone Biologic Inc

NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis

TORONTO and HAIFA, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced new laboratory data...
December 18, 2025 09:57 ET | Source: Research and Markets

Cryopreservation Bags and Freezing Bags Market Trends and Global Forecasts to 2035: Distribution by Type of Analyte Stored and Key Geographical Regions

Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Cryopreservation Bags and Freezing Bags Market: Industry Trends and Global Forecasts - Distribution by Type of Analyte Stored and Key Geographical...
December 18, 2025 09:53 ET | Source: Research and Markets

Cell Therapy Media Market to Nearly Triple by 2035, Reaching $4.5 Billion, Fueled by Advancements in FDA-Approved Cell Therapies for Various Diseases

Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Media Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Product, Type of Cell Therapy, Scale of Operation,...